Study Sheds Light into the Nature of Embryonic Stem Cells A study at the University of Edinburgh has shown that embryonic stem cells consist of cells that switch back and forth between precursors of different cell types. [Press release from EurekAlert! discussing online prepublication in PLoS Biology]
Direct Generation of Induced Pluripotent Stem Cells from Human Non-Mobilized Blood Generation of induced pluripotent stem cells from mononuclear cells of non-mobilized peripheral blood, with its relative efficiency and ease of harvesting, could enable the therapeutic use of patient-specific pluripotent stem cells. [Stem Cells Dev]
United States FDA Clears Phase 2 Trial for Cervical Spinal Fusion Australia’s regenerative medicine company, Mesoblast Limited, announced that it has received clearance from the United States Food and Drug Administration (FDA) to begin Phase 2 clinical trials of its “off-the-shelf” or allogeneic stem cell product NeoFuse™ for fusion of the cervical spine in the neck. [Mesoblast Limited Press Release]
Geron Announces Positive Study Data on GRNCM1 Geron Corporation reported positive preclinical study data showing that GRNCM1, Geron’s cardiomyocyte product derived from human embryonic stem cells, does not cause cardiac arrhythmias after transplantation into a model of chronic heart damage designed to test this potential safety concern. [Geron Corporation Press Release]
Maryland Stem Cell Research Commission Announces 42 Projects for Funding The Maryland Stem Cell Research Commission has completed its evaluation of the 141 applications in response to its three official Requests for Applications during the FY 2010 funding cycle. [Maryland Stem Cell Research Commission Press Release]
Pfizer to Cut 6,000 Jobs, Close Eight Plants Pfizer Inc. plans to eliminate 6,000 manufacturing jobs over the next 18 months to five years as it closes eight plants and reduces operations at six others. [St. Louis Business Journal]
Government Unveils $1 Billion Biomedical Tax Credit The Obama administration is offering $1 billion in seed money to small research firms in the hunt for promising medical breakthroughs. [Obama Administration, United States]
Obama Orders Review of Synthetic Biology President Obama has asked his bioethics commission to study the implications of research describing the creation of a synthetic genome. [Obama Administration, United States]
NIH Set to Tighten Financial Rules for Researchers The U.S. National Institutes of Health (NIH) proposed far-reaching changes that would lead to tighter oversight of agency-funded extramural investigators and their institutions. [National Institutes of Health, United States]
Call for Stem Cell Research Legislation The Irish Stem Cell Foundation wants legislation to be brought in this year for the use of human embryonic stem cells in Ireland. [The Irish Stem Cell Foundation, Ireland]
$2.4 Million Boost for Biotechnology Research with India Top scientists will receive funding for cutting-edge research into everything from bioenergy and biofuels to vaccines and medical diagnostics as part of a joint multi-million dollar program with India. [Indo-Australian Biotechnology Fund, Australia]